Aarey Drugs Valuation
| AAREYDRUGS | 56.29 1.60 2.93% |
At this time, the firm appears to be overvalued. Aarey Drugs Pharmace shows a prevailing Real Value of USD39.92 per share. The current price of the firm is USD56.29. Our model approximates the value of Aarey Drugs Pharmace from analyzing the firm fundamentals such as Return On Equity of 0.0374, profit margin of 0.01 %, and Current Valuation of 1.85 B as well as examining its technical indicators and probability of bankruptcy.
Price Book 1.1681 | Enterprise Value 1.9 B | Enterprise Value Ebitda 16.3188 | Price Sales 0.3374 | Trailing PE 27.75 |
Overvalued
Today
Please note that Aarey Drugs' price fluctuation is very steady at this time. Calculation of the real value of Aarey Drugs Pharmace is based on 3 months time horizon. Increasing Aarey Drugs' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Aarey stock is determined by what a typical buyer is willing to pay for full or partial control of Aarey Drugs Pharmaceuticals. Since Aarey Drugs is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Aarey Stock. However, Aarey Drugs' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 56.29 | Real 39.92 | Hype 54.69 | Naive 50.43 |
The intrinsic value of Aarey Drugs' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Aarey Drugs' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Aarey Drugs Pharmaceuticals helps investors to forecast how Aarey stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Aarey Drugs more accurately as focusing exclusively on Aarey Drugs' fundamentals will not take into account other important factors: Aarey Drugs Cash |
|
Aarey Drugs Total Value Analysis
Aarey Drugs Pharmaceuticals is presently anticipated to have takeover price of 1.85 B with market capitalization of 1.59 B, debt of 313.52 M, and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Aarey Drugs fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
1.85 B | 1.59 B | 313.52 M |
Aarey Drugs Investor Information
About 51.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 1.17. Some equities with similar Price to Book (P/B) outperform the market in the long run. Aarey Drugs Pharmace had not issued any dividends in recent years. Based on the key indicators related to Aarey Drugs' liquidity, profitability, solvency, and operating efficiency, Aarey Drugs Pharmaceuticals is not in a good financial situation at this time. It has a very high probability of going through financial hardship in December.| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Operating Income | 2.7 M | 2.8 M |
|
|
Aarey Drugs Asset Utilization
The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The latest return on assets of Aarey connotes not a very effective usage of assets in November.Aarey Drugs Ownership Allocation
Aarey Drugs holds a total of 28.35 Million outstanding shares. Aarey Drugs Pharmaceuticals retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Aarey Drugs Profitability Analysis
The company reported the revenue of 3.96 B. Net Income was 46.84 M with profit before overhead, payroll, taxes, and interest of 207.6 M.About Aarey Drugs Valuation
The stock valuation mechanism determines Aarey Drugs' current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Aarey Drugs Pharmace based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Aarey Drugs. We calculate exposure to Aarey Drugs's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Aarey Drugs's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 113 M | 79.8 M |
Aarey Drugs Quarterly Retained Earnings |
|
Additional Tools for Aarey Stock Analysis
When running Aarey Drugs' price analysis, check to measure Aarey Drugs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aarey Drugs is operating at the current time. Most of Aarey Drugs' value examination focuses on studying past and present price action to predict the probability of Aarey Drugs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aarey Drugs' price. Additionally, you may evaluate how the addition of Aarey Drugs to your portfolios can decrease your overall portfolio volatility.